- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00711750
Immediate Maintained Cannulation of a Newly Implanted Prosthetic Arteriovenous Access for Acute Hemodialysis
July 8, 2008 updated by: Far Eastern Memorial Hospital
Objectives: Examine the acute utility of immediate maintained cannulations of a newly implanted prosthetic arteriovenous access.
Background: Recurrent failure of central catheterization is not uncommon.
An alternative access is necessary for acute hemodialysis after the exhaustion of central veins.
Methods: We constructed the access by cannulating two dialysis needle-catheters and securing them on the skin after the implantation of the graft.
The access was used immediately and maintained for one week and thereafter used as a long-term access.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
39
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- Far Eastern Memorial Hospital
-
Contact:
- Chih-Yang Chan, MD, PhD
- Phone Number: 886-89667000
- Email: chanchihyang@mail.femh.org.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with end-stage renal disease underwent the specific prosthetic arteriovenous access creation in our hospital from November 2003 to October 2005 were retrospectively reviewed.
Description
Inclusion Criteria:
- end-stage renal disease underwent the specific prosthetic arteriovenous access creation in our hospital from November 2003 to October 2005
Exclusion Criteria:
- patients' poor health as long as they did not have other options and needed an access for acute hemodialysis. Exclusions included shock, active systemic infection, and rejection by the attending nephrologists
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Study Registration Dates
First Submitted
July 7, 2008
First Submitted That Met QC Criteria
July 8, 2008
First Posted (Estimate)
July 9, 2008
Study Record Updates
Last Update Posted (Estimate)
July 9, 2008
Last Update Submitted That Met QC Criteria
July 8, 2008
Last Verified
July 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FEMH-96042
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.